US expand use of Janssen’s Darzalex
The approval broadens the drug’s label to include fifth treatment option in the relapsed/refractory multiple myeloma setting
Read More
Tag: CANDOR
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
